J Rheum Dis.  2020 Jul;27(3):125-127. 10.4078/jrd.2020.27.3.125.

The Role of Immunoglobulin G4 in Patients With Rheumatoid Arthritis

• Min JK

• KMID: 2504027
• DOI: http://doi.org/10.4078/jrd.2020.27.3.125

Reference

1. French M. 1986; Serum IgG subclasses in normal adults. Monogr Allergy. 19:100–7.

2. Yu KH, Chan TM, Tsai PH, Chen CH, Chang PY. 2015; Diagnostic performance of serum IgG4 levels in patients with IgG4-related disease. Medicine (Baltimore). 94:e1707. DOI: 10.1097/MD.0000000000001707. PMID: 26469909. PMCID: PMC4616795.

3. Kamisawa T, Zen Y, Pillai S, Stone JH. 2015; IgG4-related disease. Lancet. 385:1460–71. DOI: 10.1016/S0140-6736(14)60720-0. PMID: 25481618.

4. Koneczny I. 2018; A new classification system for IgG4 autoantibodies. Front Immunol. 9:97. DOI: 10.3389/fimmu.2018.00097. PMID: 29483905. PMCID: PMC5816565.

5. Yang H, Li J, Wang Y, Ye S, Li J. 2019; Distribution characteristics of elevated serum immunoglobulin G4 (IgG4) and its relationship with IgG4-related disease. Scand J Rheumatol. 48:497–504. DOI: 10.1080/03009742.2019.1602882. PMID: 31354076.

6. Lin G, Li J. 2010; Elevation of serum IgG subclass concentration in patients with rheumatoid arthritis. Rheumatol Int. 30:837–40. DOI: 10.1007/s00296-009-1330-8. PMID: 20052478.

7. Yamamoto M, Tabeya T, Naishiro Y, Yajima H, Ishigami K, Shimizu Y, et al. 2012; Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol. 22:419–25. DOI: 10.3109/s10165-011-0532-6. PMID: 21953287.

8. Chen LF, Mo YQ, Ma JD, Luo L, Zheng DH, Dai L. 2014; Elevated serum IgG4 defines specific clinical phenotype of rheumatoid arthritis. Mediators Inflamm. 2014:635293. DOI: 10.1155/2014/635293. PMID: 25548435. PMCID: PMC4273547.

9. Kim SH, Jeong HJ, Kim JM, Jun JB, Son CN. 2020; Clinical significance of elevated serum immunoglobulin G4 levels in patients with rheumatoid arthritis. J Rheum Dis. 27:96–9. DOI: 10.4078/jrd.2020.27.2.96.

10. Cohen PL, Cheek RL, Hadler JA, Yount WJ, Eisenberg RA. 1987; The subclass distribution of human IgG rheumatoid factor. J Immunol. 139:1466–71. PMID: 3624864.

11. Engelmann R, Brandt J, Eggert M, Karberg K, Krause A, Neeck G, et al. 2008; IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA. Rheumatology (Oxford). 47:1489–92. DOI: 10.1093/rheumatology/ken336. PMID: 18703528.

12. Engelmann R, Nekarda S, Kuthning D, Kneitz C, Müller-Hilke B. 2018; Decreased IgG4 ACPA levels in responders and increased CD1c⁺ classical dendritic cells in non-responders of patients with rheumatoid arthritis under therapy. Clin Rheumatol. 37:1783–90. DOI: 10.1007/s10067-018-4053-y. PMID: 29502227.

13. Bos WH, Bartelds GM, Vis M, van der Horst AR, Wolbink GJ, van de Stadt RJ, et al. 2009; Preferential decrease in IgG4 anti-citrullinated protein antibodies during treatment with tumour necrosis factor blocking agents in patients with rheumatoid arthritis. Ann Rheum Dis. 68:558–63. DOI: 10.1136/ard.2008.088401. PMID: 18445623.

14. Carbone G, Wilson A, Diehl SA, Bunn J, Cooper SM, Rincon M. 2013; Interleukin-6 receptor blockade selectively reduces IL-21 production by CD4 T cells and IgG4 autoantibodies in rheumatoid arthritis. Int J Biol Sci. 9:279–88. DOI: 10.7150/ijbs.5996. PMID: 23493630. PMCID: PMC3596713.

15. Stone JH, Zen Y, Deshpande V. 2012; IgG4-related disease. N Engl J Med. 366:539–51. DOI: 10.1056/NEJMra1104650. PMID: 22316447.

16. Chen LYC, Mattman A, Seidman MA, Carruthers MN. 2019; IgG4-related disease: what a hematologist needs to know. Haematologica. 104:444–55. DOI: 10.3324/haematol.2018.205526. PMID: 30705099. PMCID: PMC6395313.

17. Wang W, Li J. 2011; Identification of natural bispecific antibodies against cyclic citrullinated peptide and immunoglobulin G in rheumatoid arthritis. PLoS One. 6:e16527. DOI: 10.1371/journal.pone.0016527. PMID: 21304585. PMCID: PMC3029361.

18. Kawa S. 2017; The immunobiology of immunoglobulin G4 and complement activation pathways in IgG4-related disease. Curr Top Microbiol Immunol. 401:61–73. DOI: 10.1007/82_2016_39. PMID: 27726003.

19. Holland M, Hewins P, Goodall M, Adu D, Jefferis R, Savage CO. 2004; Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass. Clin Exp Immunol. 138:183–92. DOI: 10.1111/j.1365-2249.2004.02566.x. PMID: 15373923. PMCID: PMC1809192.

20. Akiyama M, Yasuoka H, Yamaoka K, Suzuki K, Kaneko Y, Kondo H, et al. 2016; Enhanced IgG4 production by follicular helper 2 T cells and the involvement of follicular helper 1 T cells in the pathogenesis of IgG4-related disease. Arthritis Res Ther. 18:167. DOI: 10.1186/s13075-016-1064-4. PMID: 27411315. PMCID: PMC4944254.

21. Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY. 1998; IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol. 160:3555–61. PMID: 9531318.

22. Brzustewicz E, Bryl E. 2015; The role of cytokines in the pathogenesis of rheumatoid arthritis--Practical and potential application of cytokines as biomarkers and targets of personalized therapy. Cytokine. 76:527–36. DOI: 10.1016/j.cyto.2015.08.260. PMID: 26321413.

23. Costantino AB, Acosta CDV, Onetti L, Mussano E, Cadile II, Ferrero PV. 2017; Follicular helper T cells in peripheral blood of patients with rheumatoid arthritis. Reumatol Clin. 13:338–43. DOI: 10.1016/j.reuma.2016.07.003. PMID: 27595364.